Huons Global

Huons Global, established in 1965, operates as a prominent pharmaceutical and healthcare entity based in South Korea. The company focuses on the research, development, and manufacturing of diverse medical solutions designed to improve patient health outcomes. By maintaining a robust R&D pipeline, Huons Global addresses critical needs in the medical sector, specifically targeting healthcare providers and patients through specialized therapeutic offerings. The firm has successfully transitioned into a global total healthcare provider, leveraging its long-standing history to drive innovation in the pharmaceutical landscape.

The company’s product portfolio includes dental local anesthetics, weight loss medications, and a variety of medical devices. Huons Global currently maintains a workforce of 500-1,000 employees who support its operational and manufacturing requirements. With an annual revenue of $462.6M, the organization demonstrates significant market stability and financial scale within the competitive pharmaceutical industry. Its strategic focus remains on expanding its global footprint while ensuring the delivery of high-quality medical products that meet international regulatory standards. The company operates from its primary facility in Seongnam-si, Gyeonggi-do, South Korea, serving as the central hub for its research and administrative activities.

Huons Global is publicly traded on the Korea Exchange under the ticker KRX: 084110. The company continues to prioritize growth through strategic investments in medical technology and pharmaceutical advancements. Meet Huons Global's team to understand the leadership and organizational structure driving these initiatives. By integrating advanced engineering and technical expertise, the firm maintains a competitive edge in the Asia-Pacific region and beyond. Huons Global remains committed to its mission of enhancingView more...